1.1 The quality, efficacy, and safety of cannabis and prod-ucts containing cannabis extracts shall be evaluated by vali-dated testing methodologies used by trained staffed utilizing qualified instruments and/or materials.
1.2 This practice provides the cannabis industry with guid-ance for the development and validation oftesting methods that adequately evaluate cannabis and products containing cannabis extracts for quality, efficacy, and consumer health safety in the absence ofvalidated methods from agencies. This includes, but is not limited to, the potency of active substances and adulteration, including impurities stemming from potential adulteration during agricultural or manufacturing processes or both (for example, pesticides, residual solvents, and the pres-ence of fungus and microorganisms) before product approval and release for use. Depending on the methodology and precision and accuracy required, these methods may be both qualitative or quantitative.
